Similar Items: Pharmacometrics to characterize pharmacokinetics and optimize treatment in understudied populations
- Addressing challenges in the treatment of tuberculosis and tuberculosis meningitis: a pharmacometric approach
- Advancing tuberculosis treatment through pharmacometric modeling of drug exposure and biomarkers
- Population/ Nonlinear mixed-effects modelling of pharmacokinetics and pharmacodynamics of tuberculosis treatment
- Population pharmacokinetic modelling for dose optimization of esomeprazole to treat early-onset preeclampsia
- Pharmacokinetics of propofol in cats
- Aspects of the pharmacokinetics of hypoxoside in rodents
Author: Denti, Paolo
- Pharmacometric modelling to inform and improve TB and HIV treatment: Focus on drug-drug interactions and neglected populations
- Pharmacokinetics, pharmacogenetics and optimisation of treatment with non-nucleoside reverse transcriptase inhibitors in HIV-infected African children
- Population pharmacokinetic modelling to optimise treatment for children with Rifampicin-resistant TB and HIV
- Population pharmacokinetic and pharmacodynamic modelling to improve tuberculosis treatment
- A scoping review on the use of telerehabilitation in physiotherapy in low and middle income countries
- Advancing tuberculosis treatment through pharmacometric modeling of drug exposure and biomarkers